Clinical Trial: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy

U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07588100) titled 'A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy' on May 08.

Brief Summary: This study will assess the safety, tolerability, and pharmacokinetics (PK) of intravitreal (IVT) injections of RO7663498 in participants with diabetic retinopathy (DR).

Study Start Date: May 20

Study Type: INTERVENTIONAL

Condition: Diabetic Retinopathy

Intervention: DRUG: RO7663498

Participants will receive RO7663498 as per the schedule defined in the protocol.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Hoffmann-La Roche

Published b...